Patients Nationwide May Have Been Exposed to a Recalled Injectable Medication Linked to Potentially Life-Threatening Complications Including Stroke, Embolism, Organ Damage, and Death.

What Parker Waichman LLP Found

• The FDA recalled one nationwide lot of Papaverine Hydrochloride Injection after glass and paraformaldehyde contamination was discovered.
• The FDA warns foreign particles may block blood vessels, potentially causing stroke, organ damage, or death.
• The recalled injectable was distributed nationwide beginning September 30, 2025.
• Patients with cardiovascular or pulmonary conditions may face increased risks from contaminated injections.
• Individuals injured after receiving a recalled injectable medication may have the right to pursue a product liability lawsuit.

The U.S. Food and Drug Administration (FDA) has announced a nationwide recall of one lot of Papaverine Hydrochloride Injection after the manufacturer discovered foreign material inside the injectable medication. According to the FDA, testing identified the contaminants as glass and/or paraformaldehyde, creating the potential for severe and potentially fatal medical complications if the medication is administered to patients.

Injectable medications are expected to meet extremely high manufacturing standards because they are delivered directly into the bloodstream, muscle tissue, or other parts of the body without many of the natural protective barriers present when medications are taken orally. Even microscopic contaminants can create significant medical risks. When foreign particles enter the circulatory system, they may travel throughout the body and obstruct blood vessels supplying vital organs.

The recalled medication is manufactured by American Regent, Inc. The company voluntarily initiated the recall after identifying the contamination. Although the manufacturer stated that no adverse events had been reported at the time the recall was announced, the FDA emphasized that contaminated injectable medications can cause serious injuries, including blocked blood vessels, stroke, organ damage, and death.

The recall applies to a single lot of Papaverine Hydrochloride Injection that was distributed throughout the United States beginning on September 30, 2025. Because injectable medications may remain in hospital inventories, physician offices, outpatient surgery centers, pharmacies, and other healthcare facilities for extended periods, the recalled medication could still be present in medical settings months after distribution.

Patients who recently received Papaverine Hydrochloride Injection may not know the manufacturer, lot number, or whether the medication administered to them is part of the recall. Individuals who received treatment involving papaverine and later experienced unexpected medical complications should discuss their treatment history with their healthcare providers.

Why Glass and Paraformaldehyde Contamination Can Be Extremely Dangerous

Foreign particles inside injectable medications present risks that differ significantly from contamination involving many oral medications. Once an injectable drug enters the bloodstream, contaminants can circulate rapidly throughout the body.

The FDA identified the foreign material as glass and/or paraformaldehyde. Both contaminants present serious concerns.

Glass particles may vary in size from microscopic fragments to larger visible pieces. Even tiny glass particles can damage blood vessels, irritate surrounding tissue, trigger inflammation, or obstruct circulation. Because the bloodstream reaches nearly every organ, contaminated injections have the potential to affect multiple body systems.

Paraformaldehyde is a polymer related to formaldehyde. Although it has legitimate industrial and laboratory uses, it is not intended to be present in injectable medications administered to patients. The presence of paraformaldehyde inside a sterile injectable drug raises significant concerns regarding manufacturing quality and pharmaceutical safety.

According to the FDA, particulate matter introduced into the bloodstream may travel to the heart, lungs, or brain. When blood vessels become blocked, oxygen can no longer reach surrounding tissues. Depending on where the blockage occurs, patients may experience permanent injury within minutes.

Potential complications may include:

• Stroke
• Pulmonary embolic events
• Heart injury
• Organ damage
• Tissue death
• Local inflammation
• Swelling at the injection site
• Permanent disability
• Death

Because injectable medications bypass many natural defense mechanisms, contamination incidents often receive immediate attention from federal regulators.

Understanding Papaverine Hydrochloride Injection and Its Medical Uses

Papaverine Hydrochloride Injection is a prescription medication used to relax smooth muscles and widen blood vessels. It belongs to a class of medications known as vasodilators.

Healthcare providers may prescribe papaverine for several medical conditions, including poor blood circulation, visceral muscle spasms, and certain cases of erectile dysfunction. By relaxing smooth muscle tissue, the medication improves blood flow to affected areas of the body.

Unlike medications taken at home by mouth, injectable papaverine is generally administered under medical supervision. Patients receiving injections trust healthcare providers and manufacturers to ensure that sterile medications remain free from contaminants throughout the manufacturing, packaging, storage, and distribution process.

Sterility failures or particulate contamination represent significant pharmaceutical quality concerns because patients receiving injectable drugs often have underlying medical conditions that already place them at elevated risk for complications.

Many patients receiving papaverine are older adults or individuals with cardiovascular disease, vascular disorders, or circulatory problems. According to the FDA, patients with underlying cardiovascular or pulmonary conditions may face even greater risks if contaminated medication enters their bloodstream.

The FDA Warns of Potentially Catastrophic Injuries

The FDA’s warning accompanying this recall is particularly concerning because it identifies several potentially life-threatening complications associated with contaminated injectable medications.

According to the agency, foreign particles may travel through the circulatory system and lodge within blood vessels supplying the heart, lungs, or brain. When this occurs, blood flow may become partially or completely blocked.

Depending on where an obstruction develops, patients may experience symptoms including sudden weakness, paralysis, confusion, severe headache, chest pain, difficulty breathing, irregular heartbeat, loss of consciousness, or neurological impairment.

Blocked circulation affecting the brain may result in ischemic stroke. When oxygen-rich blood cannot reach brain tissue, permanent neurological damage may occur rapidly. Stroke survivors frequently require extensive rehabilitation and may experience lifelong physical, cognitive, or speech impairments.

Similarly, vascular blockages affecting the lungs or heart may become medical emergencies requiring immediate intervention.

The FDA also warned about local irritation and swelling at the injection site. While these symptoms may appear less severe than embolic complications, they may indicate inflammatory reactions or localized tissue injury requiring medical evaluation.

Prompt diagnosis and treatment often play an important role in reducing long-term complications following vascular injuries.

Pharmaceutical Manufacturing Standards Exist to Protect Patients

Manufacturers of injectable medications operate under strict federal regulations intended to ensure product sterility, purity, consistency, and safety.

Every stage of pharmaceutical production is designed to reduce contamination risks, including:

• Raw material testing
• Sterile manufacturing procedures
• Environmental monitoring
• Equipment inspection
• Particle testing
• Visual inspection
• Container integrity testing
• Quality assurance reviews

Despite these safeguards, contamination events occasionally occur because of manufacturing defects, equipment failures, packaging problems, or other quality control issues.

When contamination is discovered after distribution, manufacturers typically notify the FDA and initiate recalls to remove affected products from the marketplace before additional patients receive them.

Recalls involving injectable medications often receive heightened scrutiny because contaminated products may produce immediate and severe medical consequences.

What Patients Should Do If They Received the Recalled Medication

Patients should not panic if they previously received Papaverine Hydrochloride Injection. The recall does not necessarily mean every patient who received the medication will experience complications.

However, individuals who believe they received the recalled product should speak with their healthcare providers, particularly if they develop unusual symptoms following treatment.

The recalled product includes:

• Papaverine Hydrochloride Injection
• Strength: 60 mg/2 mL single-dose vial
• Lot Number: 25202
• NDC Number: 0517-4002-25
• Expiration Date: November 30, 2026

Healthcare providers and medical facilities have been instructed to stop using the recalled lot immediately and return or properly dispose of remaining inventory.

Patients experiencing chest pain, sudden weakness, numbness, speech difficulties, difficulty breathing, severe headaches, vision changes, or other neurological symptoms should seek immediate medical evaluation.

Medical records documenting the medication administered, lot numbers, treatment dates, and subsequent complications may become important if an investigation later determines that contamination contributed to a patient’s injuries.

Potential Legal Claims Following Contaminated Drug Injuries

Federal drug recalls frequently raise important questions regarding patient safety and corporate responsibility.

When contaminated medications allegedly cause serious injuries, legal investigations often examine whether manufacturers followed required quality control procedures, whether contamination could have been prevented, and whether appropriate testing was performed before products entered the marketplace.

Depending on the facts of each case, injured patients may pursue claims involving:

• Defective pharmaceutical manufacturing
• Manufacturing defects
• Negligence
• Failure to maintain proper quality control
• Failure to prevent contamination
• Product liability
• Wrongful death, when applicable

Individuals who suffer strokes, permanent neurological injuries, organ damage, prolonged hospitalization, or other serious complications after receiving contaminated injectable medications may incur substantial medical expenses, lost income, rehabilitation costs, and long-term care needs.

An experienced product liability investigation can determine whether the recalled medication contributed to those injuries.

Why Drug Recalls Matter Even When No Injuries Have Yet Been Reported

One important aspect of this recall is that American Regent reported no known adverse events at the time the recall was announced.

That does not necessarily mean no patients were harmed.

Drug recalls often occur before healthcare providers connect patient injuries to a particular medication lot. Some adverse events may take time to investigate, report, or confirm.

In addition, patients experiencing complications such as stroke or cardiovascular events may have underlying medical conditions that initially make it difficult to determine whether contamination played a contributing role.

Federal recalls are intended to prevent future injuries while investigations continue.

Patients and healthcare providers should remain aware of recall notices because early identification of contaminated products may reduce additional exposure and improve patient safety.

Papaverine Hydrochloride Injection Lawsuit FAQs

Can I file a lawsuit if I received the recalled Papaverine Hydrochloride Injection?

Possibly. Simply receiving the recalled medication does not automatically create a legal claim. However, if you suffered injuries such as a stroke, vascular blockage, organ damage, prolonged hospitalization, or other serious medical complications after receiving the recalled injection, you may have grounds to pursue compensation. An attorney can review your medical records, identify the medication administered, determine whether it came from the recalled lot, and evaluate whether the contaminated drug may have contributed to your injuries.

What compensation may be available in a contaminated drug lawsuit?

Patients injured by contaminated injectable medications may be entitled to recover compensation for medical expenses, future medical care, rehabilitation costs, lost wages, diminished earning capacity, pain and suffering, permanent disability, and emotional distress. If a recalled medication contributed to a fatal outcome, surviving family members may also have the right to pursue a wrongful death claim under applicable state law. Every claim depends on the specific facts, medical evidence, and the laws governing the jurisdiction where the lawsuit is filed.

How do I know whether I received the recalled medication?

Many patients are unaware of the exact medications or lot numbers used during medical treatment. Hospitals, surgical centers, infusion clinics, physician offices, and pharmacies maintain records identifying medications administered to patients. An attorney may be able to help obtain those records and determine whether the recalled lot of Papaverine Hydrochloride Injection was used during your care. Keeping copies of medical records, discharge paperwork, prescription information, and billing statements may assist with this process.

Why are contaminated injectable drugs considered more dangerous than many other recalled medications?

Injectable medications enter the body directly, allowing contaminants to circulate quickly through the bloodstream. Unlike medications taken by mouth, there are fewer natural barriers that can prevent foreign particles from reaching vital organs. If contaminants such as glass particles enter the circulation, they may travel to the brain, heart, or lungs and obstruct blood vessels. This increases the risk of severe complications including stroke, tissue damage, organ injury, and even death.

Does the absence of reported injuries mean the recalled drug was safe?

No. Drug recalls are often issued before healthcare providers recognize or report every injury associated with a contaminated medication. Some patients may experience complications weeks or months before investigators identify a connection between their medical condition and a recalled product. The FDA frequently encourages recalls as a preventive measure to stop additional exposures while investigations continue. Patients who experienced unexpected complications after receiving the recalled medication should discuss their treatment history with their physicians and consider having their case evaluated.

Contact Parker Waichman LLP For A Free Case Review

Patients trust that prescription medications administered by healthcare professionals have been manufactured according to strict safety standards. When contaminated injectable drugs enter the marketplace, the consequences can be life-changing. If you or a loved one suffered a stroke, vascular injury, organ damage, or another serious medical complication after receiving Papaverine Hydrochloride Injection, you may have legal rights worth investigating.

Parker Waichman LLP is investigating claims involving recalled pharmaceutical products and dangerous medications. The firm represents injured patients nationwide and can evaluate whether a contaminated injectable medication may have contributed to your injuries.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free consultation to discuss your potential case and learn about your legal options. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.